Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Cardiology
Volume 2017, Article ID 9231959, 4 pages
https://doi.org/10.1155/2017/9231959
Case Report

Fulminant Myocarditis Managed by Extracorporeal Life Support (Impella® CP): A Rare Case

Clinic for Cardiology, Herz- und Diabeteszentrum NRW, Ruhr-Universität Bochum, Bad Oeynhausen, Germany

Correspondence should be addressed to Henrik Fox; ed.wrn-zdh@xofh

Received 27 February 2017; Revised 22 May 2017; Accepted 15 June 2017; Published 12 July 2017

Academic Editor: Assad Movahed

Copyright © 2017 Henrik Fox et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Background. Treating myocarditis can be difficult, as clear criteria for diagnosis and management are lacking for heterogeneous clinical presentations. Case Description. We report a case of a 49-year-old female who presented with cardiogenic shock and subsequent cardiac arrest. Extracorporeal life support was instituted, and after eight days with Impella CP the patient recovered and at six months presented with normal cardiac function. Conclusion. Fulminant myocarditis remains a challenging disease in daily clinical practice, not only for diagnosis, but also for treatment. With this report we emphasize that myocardial failure due to fulminant myocarditis may be reversible if treated with extracorporeal life support, which thus plays an important and life-saving role.